Forging an Evolutionary Regulatory Path for Antibiotic Development

Although the development of antibiotics remains a challenge, there are some legislative strategies that could make it more attractive and get more players involved.

On the fourth episode of the Contagion Community podcast, Evan Loh, MD, the CEO of Paratek Pharmaceuticals, discuses passing federal legislation to improve antibiotic development and reduce antimicrobial resistance.